Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Questions to be asked at AGM (from those who cannot attend)

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Jun 09, 2023 7:28pm

196 Views

Post# 35489510

RE:Questions to be asked at AGM (from those who cannot attend)

3. What is your timeline for BTD data submission? Do you have directional feedback from the FDA that can be shared?

4. What is within your definition of commercialization and do you expect it this year?

5. What is the status of vaccine trials? Any timeline?

6. Do you have enough data to support an application for phase 1 trial of brain and lung cancer?

7. Does the HCA know you exist?

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec